Chemoinformaics analysis of 1,3,6-TRIHYDROXY-5-METHOXYXANTHEN-9-ONE
| Molecular Weight | 274.228 | nRot | 1 |
| Heavy Atom Molecular Weight | 264.148 | nRig | 17 |
| Exact Molecular Weight | 274.048 | nRing | 3 |
| Solubility: LogS | -3.609 | nHRing | 1 |
| Solubility: LogP | 2.251 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
| nHA | 6 | APOL | 34.8599 |
| nHD | 3 | BPOL | 14.3721 |
| QED | 0.587 |
| Synth | 2.498 |
| Natural Product Likeliness | 1.708 |
| NR-PPAR-gamma | 0.94 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.28 |
| HIA | 0.024 |
| CACO-2 | -4.982 |
| MDCK | 0.0000117 |
| BBB | 0.009 |
| PPB | 0.921447 |
| VDSS | 0.768 |
| FU | 0.131878 |
| CYP1A2-inh | 0.976 |
| CYP1A2-sub | 0.886 |
| CYP2c19-inh | 0.101 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.574 |
| CYP2c9-sub | 0.909 |
| CYP2d6-inh | 0.587 |
| CYP2d6-sub | 0.297 |
| CYP3a4-inh | 0.406 |
| CYP3a4-sub | 0.103 |
| CL | 8.069 |
| T12 | 0.872 |
| hERG | 0.007 |
| Ames | 0.696 |
| ROA | 0.245 |
| SkinSen | 0.882 |
| Carcinogencity | 0.069 |
| EI | 0.928 |
| Respiratory | 0.325 |
| NR-Aromatase | 0.843 |
| Antiviral | Yes |
| Prediction | 0.68611 |